| Literature DB >> 25499592 |
Astrid Torbjørnsen1, Anne Karen Jenum, Milada Cvancarova Småstuen, Eirik Arsand, Heidi Holmen, Astrid Klopstad Wahl, Lis Ribu.
Abstract
BACKGROUND: Self-management support for people with type 2 diabetes is essential in diabetes care. Thus, mobile health technology with or without low-intensity theory-based health counseling could become an important tool for promoting self-management.Entities:
Keywords: complex intervention; counseling; diabetes mellitus, type 2; life style; mHealth; mobile apps; quality of life; randomized controlled trials; self-care; telemedicine
Year: 2014 PMID: 25499592 PMCID: PMC4275473 DOI: 10.2196/mhealth.3535
Source DB: PubMed Journal: JMIR Mhealth Uhealth ISSN: 2291-5222 Impact factor: 4.773
Data collected at baseline and after 4- and 12-month follow-ups.
| Measurements | Baseline | After 4 months | After 12 months | ||
|
|
|
|
| ||
|
| Demographics, marital status, education, work situationc | X |
|
| |
|
|
|
|
| ||
|
| Related to disease, self-monitoring blood glucose, late complications (foot ulcer, eye) | X |
|
| |
|
| Comorbidityc (EU minimum dataset) | X |
|
| |
|
| Smoking and alcohol habitsc | X |
| X | |
|
|
|
|
| ||
|
| Health-related quality of life (SF-36) version 2.0 [ | X | X | X | |
|
| Depression (CES-D) [ | X | X | X | |
|
| Self-management (heiQ) [ | X | X | X | |
|
| Physical activity (from HUNT) [ | X | X | X | |
|
| Diet [ | X | X | X | |
|
| System Usability Scale [ |
| X |
| |
|
| Service user technology acceptability (SUTAQ)c,d |
|
| X | |
|
| Participation in other courses/programs during the studye |
|
| X | |
|
|
|
|
| ||
|
| Participants’ perceptions of the interventiond |
|
| X | |
|
|
|
|
| ||
|
| Diabetes medication | X |
|
| |
|
| Change in medication |
| X | X | |
|
| Medication in general |
|
| X | |
|
| Heightc | X |
|
| |
|
| Weight, blood pressure, and waist circumferencec | X |
| X | |
|
| HbA1c a | X | X | X | |
|
| Lipids | X |
| X | |
|
| Hypoglycemic events | X | X | X | |
|
| Cardiovascular complications | X |
|
| |
|
| Use of health care, expensesc |
| X | X | |
|
| General practitioners classification of diseases |
|
| X | |
|
|
|
|
|
| |
|
| Log data from FTAd | X | X | X | |
a Primary outcome.
b Secondary outcome.
c EU minimum dataset.
d Only the groups receiving a mobile phone (FTA and FTA with health counseling).
e Such as swimming, cooking, weight reduction.
Figure 1Flow diagram showing the design of the study.
Baseline characteristics of the control group and the 2 intervention groups.
| Variables | Intervention groups | Control group | |||
|
| FTA | FTA with health counseling |
| ||
|
|
|
|
| ||
|
| Age (years), mean (SD) | 58.6 (11.8) | 57.4 (12.1) | 55.9 (12.2) | |
|
| Gender (female), n (%) | 17 (33) | 25 (50) | 20 (40) | |
|
| Educational background <12 years, n (%) | 26 (51) | 26 (52) | 31 (62) | |
|
|
|
|
| ||
|
|
| 8.1 (1.1) | 8.2 (1.1) | 8.3 (1.2) | |
|
|
| HbA1c (%),median (range) | 7.8 (7.1-12.4) | 7.9 (7.1-11.3) | 7.9 (7.1-11.6) |
|
|
| HbA1c (mmol/mol), mean (SD) | 65 (12.1) | 66 (12.2) | 67 (12.7) |
|
| Comorbidity (≥2), n (%) | 28 (55) | 22 (44) | 22 (44) | |
|
| BMI (kg/m2), mean (SD) | 32.4 (6.5) | 30.7 (5.6) | 32.0 (6.0) | |
|
|
|
|
|
| |
|
|
| Normal (18.50-24.99) | 2 (4) | 7 (16) | 4 (10) |
|
|
| Preobese (25.00-29.99) | 17 (38) | 13 (30) | 11 (28) |
|
|
| Obese class I (30.00-34.99) | 13 (29) | 14 (32) | 15 (38) |
|
|
| Obese class II (35.00-39.99) | 8 (18) | 6 (14) | 6 (15) |
|
|
| Obese class III (≥40) | 5 (11) | 4 (9) | 4 (10) |
|
|
| Missing data, n | 6 | 6 | 10 |
|
|
| 98 (23) | 91 (20) | 96 (25) | |
|
|
| Missing data, n | 6 | 4 | 9 |
|
|
| 173 (10) | 171 (10) | 172 (11) | |
|
|
| Missing data, n | 6 | 6 | 10 |
|
|
|
|
|
| |
|
|
| Systolic | 136 (16.9) | 132 (13.7) | 134 (14.5) |
|
|
| Diastolic | 81 (8.2) | 79 (8.6) | 82 (9.4) |
|
|
| Missing data, n | 8 | 7 | 16 |
|
|
| 11.2 (7.3) | 9.6 (8.4) | 9.4 (5.5) | |
|
|
| Missing data, n | 3 | 5 | 5 |
|
|
|
|
| ||
|
|
|
|
|
| |
|
|
| No medication | 3 (7) | 2 (4) | 4 (11) |
|
|
| Only oral agents | 20 (44) | 27 (57) | 16 (42) |
|
|
| Only injections | 9 (20) | 7 (15) | 3 (8) |
|
|
| Combination oral/injections | 14 (30) | 11 (23) | 15 (40) |
|
|
| Missing data, n | 5 | 3 | 13 |
|
| Self-monitoring blood glucose, n (%) | 48 (94) | 45 (90) | 49 (98) | |
|
|
|
|
| ||
|
| Smoking (yes), n (%) | 5 (10) | 12 (24) | 7 (14) | |
|
|
|
|
|
| |
|
|
| Little or not engaged in physical activity | 31 (63) | 34 (68) | 33 (66) |
|
|
| Some to very engaged in physical activity | 18 (37) | 16 (32) | 17 (34) |
|
|
| Missing data, n | 2 | 0 | 0 |
Differences between responders and nonresponders at 4 months.
| Variables | Responders at 4 months | Nonrespondersa at 4 months |
| |
| Age (years), mean (SD) | 57.9 (10.7) | 55.3 (15.9) | .52b | |
| Gender (female), n (%) | 47 (39.8) | 15 (46) | .56c | |
| Education <12 years, n (%) | 68 (57.6) | 15 (46) | .21c | |
| HbA1c (%), mean (SD) | 8.2 (1.1) | 8.2 (1.1) | .74b | |
|
| 31 (6.0) | 34 (5.9) | .09b | |
|
| Missing data (BMI), n | 7 | 15 |
|
| Comorbidities ≥2, n (%) | 58 (49.2) | 14 (42) | .49c | |
|
| 10 (7.0) | 9 (7.8) | .20b | |
|
| Missing data (diabetes duration), n | 9 | 4 |
|
a Nonresponders (those without HbA1c at 4 months).
b Between-group differences tested with Mann-Whitney test.
c Between-group differences tested with chi-square test.
Changes in HbA1c between baseline and 4 months.
| Groups | Baseline | 4 months | Mean change | ||||
| Intervention | n | Mean (95% CI) | n | Mean (95% CI) | n | Mean (95% CI) | |
|
| FTA | 51 | 8.1 (7.8, 8.4) | 40 | 7.8 (7.5, 8.0) | 40 | –0.23 (–0.47, 0.01) |
|
| FTA with health counseling | 50 | 8.2 (7.9, 8.5) | 39 | 7.8 (7.4, 8.2) | 39 | –0.41 (–0.71, –0.11) |
| Control | 50 | 8.3 (8.0, 8.6) | 39 | 8.0 (7.6, 8.4) | 39 | –0.39 (–0.75, –0.03) | |
Changes in 2 heiQ domains from baseline to 4 months.
| Domain and group | Baseline | 4 months | Mean change | ||||
|
| n | Mean (95% CI) | n | Mean (95% CI) | n | Mean (95% CI) | |
|
|
|
|
|
|
|
| |
|
| FTA | 51 | 2.95 (2.82, 3.07) | 40 | 2.98 (2.81, 3.15) | 40 | 0.02 (–0.12, 0.16) |
|
| FTA with health counseling | 50 | 2.87 (2.75, 2.99) | 41 | 3.04 (2.90, 3.19) | 41 | 0.17 (0.04, 0.29) |
|
| Control | 50 | 2.92 (2.83, 3.02) | 43 | 2.92 (2.76, 3.07) | 43 | –0.04 (–0.18, 0.09) |
|
|
|
|
|
|
|
| |
|
| FTA | 51 | 3.14 (3.00, 3.28) | 40 | 3.21 (3.04, 3.37) | 40 | 0.02 (–0.10, 0.14) |
|
| FTA with health counseling | 50 | 3.08 (2.95, 3.20) | 41 | 3.27 (3.11, 3.42) | 41 | 0.22 (0.07, 0.37) |
|
| Control | 50 | 3.13 (2.98, 3.27) | 43 | 3.20 (3.05, 3.35) | 43 | 0.00 (–0.11, 0.12) |
Linear regression analysis with crude and adjusted values for HbA1c and heiQ domains from baseline to 4-month follow-up.
| Group | n | Unadjusted | Adjusteda | ||||
|
|
| Estimated β (95% CI) |
| Estimated β (95% CI) |
| ||
|
|
|
|
|
|
| ||
|
| FTA | 40 | .02 (–.40, .44) | .91 | .03 (–.40, .46) | .90 | |
|
| FTA with health counseling | 39 | .18 (–.24, .60) | .40 | .16 (–.27, .58) | .47 | |
|
| Control (ref) | 39 |
|
|
|
| |
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
| |
|
|
| FTA | 40 | –0.21 (–0.39, –0.03) | .02 | –0.22 (–0.40, –0.03) | .02 |
|
|
| FTA with health counseling | 41 | –0.14 (–0.33, 0.04) | .13 | –0.15 (–0.34, 0.03) | .11 |
|
|
| Control (ref) | 43 |
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| FTA | 40 | –0.21 (–0.39, –0.04) | .02 | –0.23 (–0.41, –0.05) | .01 |
|
|
| FTA with health counseling | 41 | –0.20 (–0.38, –0.02) | .03 | –0.19 (–0.37, –0.01) | .04 |
|
|
| Control (ref) | 43 |
|
|
|
|
a Adjusted for age, gender, and education.
Figure 2Number of blood glucose measurements during the first 4 months for the 2 intervention groups: Few Touch Application (FTA) and FTA with health counseling (HC). Time 1 (baseline): n=90; time 2: n=83; time 3: n=80; and time 4: n=79.
Figure 3Number of keystrokes during the first 4 months for the 2 intervention groups: Few Touch Application (FTA) and FTA with health counseling (HC). Time 1 (baseline): n=90; time 2: n=83; time 3: n=80; and time 4: n=79.